Masimo Corporation (MASI) Posts Earnings Results, Beats Estimates By $0.17 EPS

Masimo Corporation (NASDAQ:MASI) issued its quarterly earnings data on Tuesday. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17, Briefing.com reports. The firm had revenue of $193.69 million during the quarter, compared to analysts’ expectations of $189.01 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The business’s revenue was up 15.6% on a year-over-year basis. During the same period last year, the company earned $0.52 earnings per share.

Masimo Corporation (NASDAQ:MASI) traded up 1.06% on Tuesday, reaching $87.76. 442,952 shares of the company traded hands. The stock’s 50 day moving average price is $86.06 and its 200 day moving average price is $89.33. Masimo Corporation has a one year low of $53.78 and a one year high of $104.71. The company has a market capitalization of $4.56 billion, a PE ratio of 14.38 and a beta of 0.82.

In related news, Director Sanford Fitch sold 11,000 shares of the stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $87.25, for a total transaction of $959,750.00. Following the sale, the director now directly owns 72,249 shares of the company’s stock, valued at approximately $6,303,725.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 16.60% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Masimo Corporation (MASI) Posts Earnings Results, Beats Estimates By $0.17 EPS” was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://www.com-unik.info/2017/10/31/masimo-corporation-masi-posts-earnings-results-beats-estimates-by-0-17-eps.html.

A number of brokerages have recently issued reports on MASI. Zacks Investment Research cut shares of Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Roth Capital boosted their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a report on Monday, August 14th. Finally, Stifel Nicolaus assumed coverage on shares of Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 price target on the stock. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. Masimo Corporation presently has a consensus rating of “Hold” and a consensus price target of $97.00.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Earnings History for Masimo Corporation (NASDAQ:MASI)

What are top analysts saying about Masimo Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit